NAMD Letter to HRSA, CMS on 340B Drug Discount Program

NAMD sent a letter to the Health Resources and Services Administration (HRSA) and the Centers for Medicare and Medicaid Services (CMS) to share our recent white paper discussing operational challenges in Medicaid’s interaction with the 340B drug discount program. The white paper is available here.

Read the full letter here.

Comments are closed.